Von Willebrand Disease
📧 Sign up to get email alerts when something new happens for Von Willebrand Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-05-28FDA Approved: DESMOPRESSIN ACETATE — Original Application (Glenmark Pharmaceuticals Inc.,USA)
The FDA approved Glenmark's Desmopressin Acetate as an Original Application (ANDA201831), authorizing the generic product to be marketed for…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery [Phase 3]
Phase 3 study of Wilate for preventing bleeding in Von Willebrand disease patients undergoing major surgery has completed, with results post…
-
FDA approval · 2015-01-23FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp. under an ANDA.
-
FDA approval · 2015-01-14FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)
FDA approved a supplemental application for desmopressin acetate from Bauch & Lomb Incorporated under an ANDA.
-
CLINICAL_TRIALS withdrawal · 2014-12-05Clinical Trial Update: Changes in Bleeding and Clotting During the Menstrual Cycle
A clinical trial investigating bleeding and clotting during the menstrual cycle in individuals with von Willebrand disease (and healthy cont…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia [Phase 2]
Phase 2 trial update on IL-11 for women with von Willebrand disease and refractory menorrhagia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-11-07Clinical Trial Update: IL-11 in Adults With Von Willebrand Disease Undergoing Surgery [Phase 2]
Phase 2 trial investigating IL-11 in adults with Von Willebrand Disease undergoing surgery was terminated; results posted in 2014.
-
FDA approval · 2014-02-28FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for DDAVP (desmopressin acetate) filed by Ferring Pharmaceuticals Inc. The action updates the pr…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador
A clinical trial conducted in Cuenca, Ecuador, studying von Willebrand disease and hemophilia A and B, has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
This clinical trial update reports changes in thrombin generation potential and thromboelastography during the menstrual cycle in individual…
-
FDA approval · 2013-01-25FDA Approved: DESMOPRESSIN ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved an Abbreviated New Drug Application for Desmopressin Acetate from Sun Pharmaceutical Industries, marking a generic product appr…
-
CLINICAL_TRIALS trial_result · 2011-09-30Clinical Trial Update: Acquired Von Willebrand Syndrome in Severe Aortic Stenosis
This completed clinical trial investigated acquired von Willebrand syndrome in patients with severe aortic stenosis and its association with…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) [Phase 4]
Phase 4 study assessing safety and efficacy of the Antihemophilic Factor/Von Willebrand Factor Complex in surgical subjects with von Willebr…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)
A completed Canadian clinical trial assessing the safety of Humate-P with reduced infusion volume in Von Willebrand Disease.
-
CLINICAL_TRIALS research · 2010-12-17Clinical Trial Update: Evaluation of Menses in Congenital Bleeding Disorders
This Clinical Trial Update reports on ongoing evaluation of menses in individuals with congenital bleeding disorders, including von Willebra…
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: National Study of Moderate and Severe Von Willebrand Disease in the Netherlands
The national study of moderate and severe Von Willebrand disease in the Netherlands has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Optivate in People With Von Willebrand Disease Undergoing Surgery [Phase 3]
Phase 3 trial of Optivate for von Willebrand disease in patients undergoing surgery has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: A Study With OPTIVATE® in People With Von Willebrand Disease [Phase 3]
A Phase 3 clinical trial of OPTIVATE in people with Von Willebrand Disease was terminated.
-
CLINICAL_TRIALS withdrawal · 2009-08-21Clinical Trial Update: A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B [Phase 2]
A Phase 2 trial evaluating ARC1779 for Von Willebrand Disease Type 2B was withdrawn, with the study status changed to withdrawn.
-
FDA approval · 2009-03-27FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Desmopressin Acetate submitted by Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2008-09-19Clinical Trial Update: The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders [NA]
Clinical trial update reports completion of a study on the use of Cyclokapron (tranexamic acid) for treatment and management of bleeding dis…
-
FDA approval · 2008-09-03FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., indicating an addition or modification to the approved p…
-
FDA label_change · 2008-04-25FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)
FDA approved a supplemental application for Desmopressin Acetate from Bauch & Lomb Incorporated, indicating changes to labeling or related r…
-
FDA approval · 2008-03-11FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp., updating the approved generic product. The action formal…
-
FDA approval · 2007-10-26FDA Approved: DDAVP — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for DDAVP (desmopressin acetate) from Ferring Pharmaceuticals Inc., updating the product's labeling.